Mepolizumab therapy decreases epithelial‐derived cytokine concentrations in exhaled breath condensates from patients with severe eosinophilic asthma-Reference-Cited by-同舟云学术

Mepolizumab therapy decreases epithelial‐derived cytokine concentrations in exhaled breath condensates from patients with severe eosinophilic asthma

Published:2023-04-13 Issue:8 Volume:53 Page:846-849
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Likońska Aleksandra¹,Nowak‐Jurek Alicja¹,Gajewski Adrian¹,Antczak‐Marczak Monika¹,Frachowicz‐Guerreiro Karolina¹,Wardzyńska Aleksandra¹^ORCID,Chałubiński Maciej¹^ORCID

Affiliation:

1. Department of Immunology and Allergy, Chair of Pulmonology, Rheumatology and Clinical Immunology Medical University of Lodz, Poland Lodz Poland

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14316

Reference8 articles.

1. Cytokines in serum, nasal secretion and exhaled breath condensate during mepolizumab therapy in patients with different phenotypes of severe eosinophilic asthma: A pilot study

2. Serum Levels of Epithelial-Derived Cytokines as Interleukin-25 and Thymic Stromal Lymphopoietin after a Single Dose of Mepolizumab in Patients with Severe Non-Allergic Eosinophilic Asthma: A Short Report

3. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps

4. Type 2 immunity in the skin and lungs

5. Periostin in Allergy and Inflammation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of IL‐5 in asthma and airway remodelling;Clinical & Experimental Allergy;2024-06-27